SlideShare a Scribd company logo
1 of 28
1
CATH
MEET
UNIT IAA
Presenter-Praveen Gupta
28-01-2017
Cath Study in
a patient with
VSD
History
 A 40 year old female resident of Bankura, West Bengal came to JIPMER
hospital cardiology OPD with chief complaints of
 Dypnoea on exertion NYHA Class III since 2 month
 Chest pain since last one month
2
On examination
 Cyanosis+/Clubbing +/Icterus-/LAP-
 Pulse- 71 beats per min
 BP-110/70 mmhg
 CVS-S1S2 + S2 Loud
 RS-Bilateral NVBS+
 SPO2-90%
3
Investigation
 Hb-15.5
 Platelet count 1.5 lacs
 RBS-74
 BUN-33
 S.Creatinine-1.4
 Uric acid-2.5
 HIV-NR
 HBsAg-NR
 Anti HCV- Negative
 Body weight-37 kgs
 Height-144 cms
4
Investigation
 ECG-Normal sinus rhythm at 60 beats per minute, right axis deivation,
right ventricular hypertrophy
 Echocardiography Large muscular VSD with bidirectional shunt was
present, Severe tricuspid regurgitaion with RVSP 130 mmhg, IAS was
intact, no PDA, CoA, Normal biventricular function
5
Course in the hospital
 VSD with Severe pulmonary hypertension
 Planned for cardiac catheterization to look for feasbility for surgical repair.
 But cardiac catheterization was not possible in view of logistic reason so
patient was discharged and advised to follow up in cardiology OPD.
 Patient was started on tablet Sildenafil 25 mg TDS
 Patient again visited JIPMER after six month
 During this admission her Spo2 was 95%, and she was found to be HCV
positive
 So cath study was planned
6
Cath study (Oximetery run )
Pre-oxygenation Post oxygentaion (100%
O2)
SVC 58.8% 70.8%
IVC 74.9% 75.9%
Right atrium 62% 84%
Right ventricle 77.3% 91.1%
Pulmonary artery 87.4% 91.2%
Pulmonary vein 92.7% 98.3%
Left atrium 88.1% 96%
Left ventricle 96% 99.3%
Aorta 92.1% 94.5%
Mixed venous oxygen
satuation
62.82% 72.07
7
Saturation pre-oxygenation
62.0
%
77.3
%
58.8%
96 %
87.4
%
92.1
% 88.1
%
74.9 %
92.7
%
8
Saturation postoxygenation
84.0
%
91.1
%
70.8%
99.3
%
91.2
%
94.5
% 96 %
75.9 %
98.3
%
9
Pressure in various cardiac chamber during cath
study(Post-oxygenation)
Systolic pressure
(mmhg)
Diastolic pressure
(mmhg)
Mean
Pressure(mmhg)
Right atrium 6
Left atrium 6
Pulmonary artery 88 40 62
Aorta 98 67 77
10
Oxygen content calculation
Chamber Oxygen content calculation Oxygen
content
SVC 0.136X10X70.8+0.03X63 98.17
IVC 0.136 X 10 X 75.9 + 0.03 X 52 104.784
Pul Artery 0.136 x 10 x91.2 + 0.03 x 132 127.992
Pul venous 0.136 X 10 X 98.3 + 0.03 X 450 147.188
Aorta 0.136 x 10 x 94.5 + 0.03 x 40.4 140.64
Mixed
venous
oxyg
saturation
3 x SCV + 1 X IVC/ 4 99.82
11
Cath study data
BSA 1.22 m2
Vmax 150 x BSA 184.37
Qs(Systemic blood
flow)
Vmax/Ao2-MVo2 4.51
Qp(Pulmonary
blood flow)
Vmax/Pvo2-Pao2 9.60
Qp/QS 9.60/4.51 2.12
EBF(Effective
blood flow)
Vmax/Pvo2-MVo2 4.091
12
Cath study data
PVR Pa(mean)-LA(mean)/Qp 62-6/9.60 5.88 wood unit
SVR Ao(mean)-RA(mean)/Qs 77-6/4.51 15.63 wood unit
PVR/SVR 5.88/12.41 0.3761
L-R Shunt PBF-EBF 9.60-4.091 5.509
R-L Shunt SBF-EBF 4.51-4.091 0.419
13
Conclusion
 VSD/Severe PAH/Bidirectional shunt/moderate pulmonary vascular
resistance
 Plan-Medical management with intracardiac repair for VSD
14
Shunt Determinations
 Normally, PBF and SBF are equal
 With abnormal communication between intracardiac chambers or great vessels, blood flow is
shunted from the systemic circulation to the pulmonary circulation (left-to-right shunt), from
the pulmonary circulation to the systemic circulation (right-to-left shunt), or in both
directions (bidirectional shunt).
 Most commonly method for shunt determination, oximetric method
 Unexplained pulmonary artery oxygen saturation > 80% raise suspicion for left-to-right shunt
 Unexplained arterial desaturation (<93%) indicate a right-to-left shunt
 If arterial desaturation persists after the patient takes several deep breaths or after
administration of 100% oxygen, a right-to-left shunt is likely
15
Oximetric Method
 The oximetric method is based on blood sampling from various cardiac chambers for
determination of oxygen saturation
 Left-to-right shunt is detected when a significant increase in blood oxygen saturation is found
between two right-sided vessels or chambers
 Obtains blood samples from all right-sided locations
 A full saturation run obtains samples from the high and low IVC; high and low SVC; high,
middle, and low right atrium; RV inflow and outflow tracts and midcavity; main pulmonary
artery; left or right pulmonary artery; pulmonary vein and left atrium, if possible; left
ventricle; and distal aorta
16
Shunt Quantification
 To determine left to- right shunt, PBF and
SBF required
 Principles of Fick cardiac output are used
to quantify intracardiac shunts
 PBF is oxygen consumption/ difference in
oxygen content across pulmonary bed
 SBF is oxygen consumption/difference in
oxygen content across the systemic bed
 Effective blood flow (EBF) is the fraction
of mixed venous return received by the
lungs without contamination by shunt flow
 In the absence of a shunt, PBF, SBF, and
EBF are all equal
17
Shunt Quantification
where PvO2, PaO2, SaO2, and MvO2 are the oxygen content (in milliliters of
oxygen per liter of blood) of pulmonary venous, pulmonary arterial, systemic
arterial, and mixed venous blood, respectively
18
Shunt Quantification
 The mixed venous oxygen content is the average oxygen content of blood in the
chamber proximal to the shunt.
 When assessing a left-to-right shunt at the level of the right atrium, one must
calculate the mixed venous oxygen content on the basis of the contributing blood
flow from the IVC, SVC, and coronary sinus.
 The most commonly used method is the Flamm formula
19
Shunt Quantification
 Assuming conservation of mass, the size of a left-to-right shunt, when no associated right-to-
left shunt is present, is simply
LR shunt = PBF − SBF
 When there is evidence of a right-to-left shunt in addition to a left to- right shunt (also
referred to as a bidirectional shunt), the approximate size of the left-to-right shunt is
LR shunt = PBF − EBF
 Approximate size of the right-to-left shunt is
RL shunt = SBF − EBF
20
Shunt Quantification
 Flow ratio PBF/SBF (or Qp/Qs) is used clinically to determine the significance of the shunt
 Ratio of less than 1.5 indicates a small left-to-right shunt
 Ratio of 1.5 to 2.0, a moderate-sized shunt
 Ratio of 2.0 or higher indicates a large left-to-right shunt
 A flow ratio of less than 1.0 indicates a net right-to-left shunt
21
Various formula used are---
 A-VO2 is the arterial-venous oxygen saturation
difference
 Hgb is the hemoglobin concentration (mg/dL),
and the constant 1.36 is the oxygen-carrying
capacity of hemoglobin (expressed in mL O2/g
Hgb)
 Systemic vascular resistance (SVR) in absolute
units is calculated with the following equation:
 Aom and RAm are the mean pressure (in mm Hg)
in the aorta and right atrium, respectively, and Qs
is systemic cardiac output (in liters/min).
 The constant 80 is used to convert units from mm
Hg/liter/ min (Wood units) to the absolute
resistance units dyne-sec • cm−5
22
Various formula used are---
 where PAm and LAm are mean pulmonary
artery and left atrial pressure, respectively, and
Qp is PBF.
 If mean left atrial pressure has not been
measured directly, mean pulmonary capillary
wedge pressure is commonly substituted for it,
although errors can occur because of this
substitution.
 In the absence of an intracardiac shunt, Qp is
equal to systemic cardiac output.
 PVR describes the pressure across the major
pulmonary vessels and the precapillary
arterioles and pulmonary
23
24
Operative criteria in a patient with intracardia shunt
25
Operative criteria
26
 The use of a PVR of 6 Wood units m2 and a PVR∶SVR ratio of 0.3 as limits for considering
operation in PAH-CHD was proposed in a previously published consensus
 20% decrease in PVR from baseline during the acute vasodilator test was considered
sufficient to define a positive response but not to characterize operability
 More recently, during the 5th World Symposium on Pulmonary Hypertension of the World
Health Organization (Nice, France, February 2013), a PVR of 4 Wood units m2 was proposed
as a limit for considering surgery, and a PVR of 4–8 Wood units m2 as the range in which
patients should be discussed case by case.
Operative criteria
27
 The Pediatric Task Force also concluded that at present, there is no
established protocol for the vasodilator test in children and no evidence to
use it for prognostic purposes.
 There has been debate about what to do with patients with elevated PVR
(e.g., PVR > 8–10 Wood units m2and PVR∶SVR > 0.5), in particular since
the answer will not be the same for patients at different ages
28

More Related Content

What's hot

Contrast Echocardiography
Contrast EchocardiographyContrast Echocardiography
Contrast EchocardiographyAdhi Arya
 
Angulated views in coronary angiography,an introductory lecture for cath lab ...
Angulated views in coronary angiography,an introductory lecture for cath lab ...Angulated views in coronary angiography,an introductory lecture for cath lab ...
Angulated views in coronary angiography,an introductory lecture for cath lab ...LPS Institute of Cardiology Kanpur UP India
 
FFR(fractional flow reserve)
FFR(fractional flow reserve)FFR(fractional flow reserve)
FFR(fractional flow reserve)DIPAK PATADE
 
Pressure, Damping and Ventricularization_Crimson Publishers
Pressure, Damping and Ventricularization_Crimson PublishersPressure, Damping and Ventricularization_Crimson Publishers
Pressure, Damping and Ventricularization_Crimson PublisherscrimsonpublishersOJCHD
 
Percutaneous Pulmonary Valve Interventions
Percutaneous Pulmonary Valve InterventionsPercutaneous Pulmonary Valve Interventions
Percutaneous Pulmonary Valve InterventionsPraveen Nagula
 
Shunt quantification
Shunt quantificationShunt quantification
Shunt quantificationAnkur Gupta
 
Diagnostic catheters for coronary angiography
Diagnostic catheters for coronary angiography Diagnostic catheters for coronary angiography
Diagnostic catheters for coronary angiography Aswin Rm
 
Coronary anatomy and angiographic views
Coronary anatomy and angiographic viewsCoronary anatomy and angiographic views
Coronary anatomy and angiographic viewsthanigai arasu
 
Right heart catheterization
 Right heart catheterization Right heart catheterization
Right heart catheterizationToufiqur Rahman
 
Stress echocardiography
Stress echocardiographyStress echocardiography
Stress echocardiographyFuad Farooq
 
Echocardiographic Evaluation of LV Diastolic Function
Echocardiographic Evaluation of LV Diastolic FunctionEchocardiographic Evaluation of LV Diastolic Function
Echocardiographic Evaluation of LV Diastolic FunctionJunhao Koh
 

What's hot (20)

Contrast Echocardiography
Contrast EchocardiographyContrast Echocardiography
Contrast Echocardiography
 
Angulated views in coronary angiography,an introductory lecture for cath lab ...
Angulated views in coronary angiography,an introductory lecture for cath lab ...Angulated views in coronary angiography,an introductory lecture for cath lab ...
Angulated views in coronary angiography,an introductory lecture for cath lab ...
 
FFR(fractional flow reserve)
FFR(fractional flow reserve)FFR(fractional flow reserve)
FFR(fractional flow reserve)
 
Normal variants of heart structures
Normal variants of heart structuresNormal variants of heart structures
Normal variants of heart structures
 
cath Lab Hemoduhynamic
cath Lab Hemoduhynamiccath Lab Hemoduhynamic
cath Lab Hemoduhynamic
 
Lv systolic function
Lv systolic functionLv systolic function
Lv systolic function
 
Pressure, Damping and Ventricularization_Crimson Publishers
Pressure, Damping and Ventricularization_Crimson PublishersPressure, Damping and Ventricularization_Crimson Publishers
Pressure, Damping and Ventricularization_Crimson Publishers
 
Percutaneous Pulmonary Valve Interventions
Percutaneous Pulmonary Valve InterventionsPercutaneous Pulmonary Valve Interventions
Percutaneous Pulmonary Valve Interventions
 
Contrast echocardiography
Contrast echocardiography Contrast echocardiography
Contrast echocardiography
 
Shunt quantification
Shunt quantificationShunt quantification
Shunt quantification
 
Coronary guide wires
Coronary guide wires  Coronary guide wires
Coronary guide wires
 
Rotablation
RotablationRotablation
Rotablation
 
Cardiac catheters
Cardiac cathetersCardiac catheters
Cardiac catheters
 
Diagnostic catheters for coronary angiography
Diagnostic catheters for coronary angiography Diagnostic catheters for coronary angiography
Diagnostic catheters for coronary angiography
 
TAVI
TAVI TAVI
TAVI
 
Coronary anatomy and angiographic views
Coronary anatomy and angiographic viewsCoronary anatomy and angiographic views
Coronary anatomy and angiographic views
 
Right heart catheterization
 Right heart catheterization Right heart catheterization
Right heart catheterization
 
Stress echocardiography
Stress echocardiographyStress echocardiography
Stress echocardiography
 
Echo assessment of RV function
Echo assessment of RV functionEcho assessment of RV function
Echo assessment of RV function
 
Echocardiographic Evaluation of LV Diastolic Function
Echocardiographic Evaluation of LV Diastolic FunctionEchocardiographic Evaluation of LV Diastolic Function
Echocardiographic Evaluation of LV Diastolic Function
 

Viewers also liked

DANISH trial (Cardiology)
 DANISH trial (Cardiology) DANISH trial (Cardiology)
DANISH trial (Cardiology)PRAVEEN GUPTA
 
Risk stratification in ARVC
Risk stratification in ARVCRisk stratification in ARVC
Risk stratification in ARVCPRAVEEN GUPTA
 
Acute myocardial infarction in women
Acute myocardial infarction in womenAcute myocardial infarction in women
Acute myocardial infarction in womenPRAVEEN GUPTA
 
DM cardiology Exam Spotter
DM cardiology Exam SpotterDM cardiology Exam Spotter
DM cardiology Exam SpotterPRAVEEN GUPTA
 
Echocardiography assessment of Aortic Regurgitation severity
Echocardiography assessment of Aortic Regurgitation severityEchocardiography assessment of Aortic Regurgitation severity
Echocardiography assessment of Aortic Regurgitation severityPRAVEEN GUPTA
 
Cardiology window Blog
Cardiology window BlogCardiology window Blog
Cardiology window BlogPRAVEEN GUPTA
 
2016 acc focused update on new pharmacological therapy for heart failure
2016 acc focused update on new pharmacological therapy for heart failure2016 acc focused update on new pharmacological therapy for heart failure
2016 acc focused update on new pharmacological therapy for heart failurePRAVEEN GUPTA
 
Kultura ekintzailea garatzeko jarduerak zitek programa 2014 2015
Kultura ekintzailea garatzeko jarduerak zitek programa 2014 2015Kultura ekintzailea garatzeko jarduerak zitek programa 2014 2015
Kultura ekintzailea garatzeko jarduerak zitek programa 2014 2015emprendedoreszitek
 
Teoriasorganizativas
TeoriasorganizativasTeoriasorganizativas
TeoriasorganizativasSmith Smithe
 
Herbs self defense
Herbs self defenseHerbs self defense
Herbs self defenseJaco Ba
 
Роль Информационно-библиотечного центра в создании единого образовательного п...
Роль Информационно-библиотечного центра в создании единого образовательного п...Роль Информационно-библиотечного центра в создании единого образовательного п...
Роль Информационно-библиотечного центра в создании единого образовательного п...Sergey Kamalov
 
Final slide quiz
Final slide quizFinal slide quiz
Final slide quizanidla
 

Viewers also liked (20)

DANISH trial (Cardiology)
 DANISH trial (Cardiology) DANISH trial (Cardiology)
DANISH trial (Cardiology)
 
Cardiology exam MCQ
Cardiology exam MCQCardiology exam MCQ
Cardiology exam MCQ
 
Risk stratification in ARVC
Risk stratification in ARVCRisk stratification in ARVC
Risk stratification in ARVC
 
Acute myocardial infarction in women
Acute myocardial infarction in womenAcute myocardial infarction in women
Acute myocardial infarction in women
 
DM cardiology Exam Spotter
DM cardiology Exam SpotterDM cardiology Exam Spotter
DM cardiology Exam Spotter
 
Echocardiography assessment of Aortic Regurgitation severity
Echocardiography assessment of Aortic Regurgitation severityEchocardiography assessment of Aortic Regurgitation severity
Echocardiography assessment of Aortic Regurgitation severity
 
Cardiology window Blog
Cardiology window BlogCardiology window Blog
Cardiology window Blog
 
Cardiology 101 back to the basics
Cardiology 101 back to the basicsCardiology 101 back to the basics
Cardiology 101 back to the basics
 
Pericardiocentesis
PericardiocentesisPericardiocentesis
Pericardiocentesis
 
2016 acc focused update on new pharmacological therapy for heart failure
2016 acc focused update on new pharmacological therapy for heart failure2016 acc focused update on new pharmacological therapy for heart failure
2016 acc focused update on new pharmacological therapy for heart failure
 
Asd and vsd
Asd and vsdAsd and vsd
Asd and vsd
 
Kultura ekintzailea garatzeko jarduerak zitek programa 2014 2015
Kultura ekintzailea garatzeko jarduerak zitek programa 2014 2015Kultura ekintzailea garatzeko jarduerak zitek programa 2014 2015
Kultura ekintzailea garatzeko jarduerak zitek programa 2014 2015
 
Water Structure
Water StructureWater Structure
Water Structure
 
Teoriasorganizativas
TeoriasorganizativasTeoriasorganizativas
Teoriasorganizativas
 
Trabajo Internet
Trabajo InternetTrabajo Internet
Trabajo Internet
 
Resume
ResumeResume
Resume
 
La web 2.0
La web 2.0 La web 2.0
La web 2.0
 
Herbs self defense
Herbs self defenseHerbs self defense
Herbs self defense
 
Роль Информационно-библиотечного центра в создании единого образовательного п...
Роль Информационно-библиотечного центра в создании единого образовательного п...Роль Информационно-библиотечного центра в создании единого образовательного п...
Роль Информационно-библиотечного центра в создании единого образовательного п...
 
Final slide quiz
Final slide quizFinal slide quiz
Final slide quiz
 

Similar to Cardiac catheteriztion, Oximetery study in a patient with VSD

Shunt quantification and reversibility
Shunt quantification and reversibilityShunt quantification and reversibility
Shunt quantification and reversibilityGOPAL GHOSH
 
Shunt quantification
Shunt quantificationShunt quantification
Shunt quantificationGirish Mishra
 
Intracardiac shunts
Intracardiac shuntsIntracardiac shunts
Intracardiac shuntsFuad Farooq
 
Hemodynamic parameters & fluid therapy Asim
Hemodynamic parameters &  fluid therapy AsimHemodynamic parameters &  fluid therapy Asim
Hemodynamic parameters & fluid therapy AsimMuhammad Asim Rana
 
Hemodynamic monitoring.pptx
Hemodynamic monitoring.pptxHemodynamic monitoring.pptx
Hemodynamic monitoring.pptxGETAYE5
 
EuroPCR CV pipeline, Kovarnik
EuroPCR CV pipeline, KovarnikEuroPCR CV pipeline, Kovarnik
EuroPCR CV pipeline, KovarnikMirek Navratil
 
Perplexing PH Case 2
Perplexing PH Case 2Perplexing PH Case 2
Perplexing PH Case 2Duke Heart
 
Pulmonary Artery Catheter Questionnaire
Pulmonary Artery Catheter QuestionnairePulmonary Artery Catheter Questionnaire
Pulmonary Artery Catheter Questionnaireshivabirdi
 
Assessment of shunt by cardiac catheterization
Assessment of shunt by cardiac catheterizationAssessment of shunt by cardiac catheterization
Assessment of shunt by cardiac catheterizationMalleswara rao Dangeti
 
REVIEW OF HEMODYNAMIC MONITORING
REVIEW OF HEMODYNAMIC MONITORINGREVIEW OF HEMODYNAMIC MONITORING
REVIEW OF HEMODYNAMIC MONITORINGGhaleb Almekhlafi
 
His Resynchronization Versus Biventricular Pacing in Patients With Heart Fail...
His Resynchronization VersusBiventricular Pacing inPatients With Heart Fail...His Resynchronization VersusBiventricular Pacing inPatients With Heart Fail...
His Resynchronization Versus Biventricular Pacing in Patients With Heart Fail...Shadab Ahmad
 
Uncalibrated pulse contour derived stroke volume variation predicts[1]
Uncalibrated pulse contour derived stroke volume variation predicts[1]Uncalibrated pulse contour derived stroke volume variation predicts[1]
Uncalibrated pulse contour derived stroke volume variation predicts[1]pbsherren
 
HEMODYNAMICS MONITORING IN CRITICALLY ILL PATIENTS: ASSESSMENT OF FLUID STATU...
HEMODYNAMICS MONITORING IN CRITICALLY ILL PATIENTS: ASSESSMENT OF FLUID STATU...HEMODYNAMICS MONITORING IN CRITICALLY ILL PATIENTS: ASSESSMENT OF FLUID STATU...
HEMODYNAMICS MONITORING IN CRITICALLY ILL PATIENTS: ASSESSMENT OF FLUID STATU...Bassel Ericsoussi, MD
 
Hemodynamic Pressure Monitoring
Hemodynamic Pressure MonitoringHemodynamic Pressure Monitoring
Hemodynamic Pressure MonitoringKhalid
 
Hemodynamic monitoring in ICU
Hemodynamic monitoring in ICUHemodynamic monitoring in ICU
Hemodynamic monitoring in ICUManoj Prabhakar
 
Xavier Monnet - Monitoring hd pi cco java porto - IFAD 2012
Xavier Monnet - Monitoring hd pi cco java porto - IFAD 2012Xavier Monnet - Monitoring hd pi cco java porto - IFAD 2012
Xavier Monnet - Monitoring hd pi cco java porto - IFAD 2012International Fluid Academy
 

Similar to Cardiac catheteriztion, Oximetery study in a patient with VSD (20)

Shunt quantification and reversibility
Shunt quantification and reversibilityShunt quantification and reversibility
Shunt quantification and reversibility
 
oxymetery.pptx
oxymetery.pptxoxymetery.pptx
oxymetery.pptx
 
Shunt quantification
Shunt quantificationShunt quantification
Shunt quantification
 
Intracardiac shunts
Intracardiac shuntsIntracardiac shunts
Intracardiac shunts
 
Hemodynamic parameters & fluid therapy Asim
Hemodynamic parameters &  fluid therapy AsimHemodynamic parameters &  fluid therapy Asim
Hemodynamic parameters & fluid therapy Asim
 
Hemodynamic monitoring.pptx
Hemodynamic monitoring.pptxHemodynamic monitoring.pptx
Hemodynamic monitoring.pptx
 
EuroPCR CV pipeline, Kovarnik
EuroPCR CV pipeline, KovarnikEuroPCR CV pipeline, Kovarnik
EuroPCR CV pipeline, Kovarnik
 
Perplexing PH Case 2
Perplexing PH Case 2Perplexing PH Case 2
Perplexing PH Case 2
 
Pulmonary Artery Catheter Questionnaire
Pulmonary Artery Catheter QuestionnairePulmonary Artery Catheter Questionnaire
Pulmonary Artery Catheter Questionnaire
 
Assessment of shunt by cardiac catheterization
Assessment of shunt by cardiac catheterizationAssessment of shunt by cardiac catheterization
Assessment of shunt by cardiac catheterization
 
Advanced Hemodynamics
Advanced HemodynamicsAdvanced Hemodynamics
Advanced Hemodynamics
 
REVIEW OF HEMODYNAMIC MONITORING
REVIEW OF HEMODYNAMIC MONITORINGREVIEW OF HEMODYNAMIC MONITORING
REVIEW OF HEMODYNAMIC MONITORING
 
His Resynchronization Versus Biventricular Pacing in Patients With Heart Fail...
His Resynchronization VersusBiventricular Pacing inPatients With Heart Fail...His Resynchronization VersusBiventricular Pacing inPatients With Heart Fail...
His Resynchronization Versus Biventricular Pacing in Patients With Heart Fail...
 
Monitoring in ICU
Monitoring in ICUMonitoring in ICU
Monitoring in ICU
 
Barseghia-Basic-Hemodynamics.pptx
Barseghia-Basic-Hemodynamics.pptxBarseghia-Basic-Hemodynamics.pptx
Barseghia-Basic-Hemodynamics.pptx
 
Uncalibrated pulse contour derived stroke volume variation predicts[1]
Uncalibrated pulse contour derived stroke volume variation predicts[1]Uncalibrated pulse contour derived stroke volume variation predicts[1]
Uncalibrated pulse contour derived stroke volume variation predicts[1]
 
HEMODYNAMICS MONITORING IN CRITICALLY ILL PATIENTS: ASSESSMENT OF FLUID STATU...
HEMODYNAMICS MONITORING IN CRITICALLY ILL PATIENTS: ASSESSMENT OF FLUID STATU...HEMODYNAMICS MONITORING IN CRITICALLY ILL PATIENTS: ASSESSMENT OF FLUID STATU...
HEMODYNAMICS MONITORING IN CRITICALLY ILL PATIENTS: ASSESSMENT OF FLUID STATU...
 
Hemodynamic Pressure Monitoring
Hemodynamic Pressure MonitoringHemodynamic Pressure Monitoring
Hemodynamic Pressure Monitoring
 
Hemodynamic monitoring in ICU
Hemodynamic monitoring in ICUHemodynamic monitoring in ICU
Hemodynamic monitoring in ICU
 
Xavier Monnet - Monitoring hd pi cco java porto - IFAD 2012
Xavier Monnet - Monitoring hd pi cco java porto - IFAD 2012Xavier Monnet - Monitoring hd pi cco java porto - IFAD 2012
Xavier Monnet - Monitoring hd pi cco java porto - IFAD 2012
 

More from PRAVEEN GUPTA

Praveen's Indian cardiology board review and self-assessment
Praveen's Indian cardiology board review and self-assessmentPraveen's Indian cardiology board review and self-assessment
Praveen's Indian cardiology board review and self-assessmentPRAVEEN GUPTA
 
Evaluation and management of Pacemaker malfunction
Evaluation and management of Pacemaker malfunctionEvaluation and management of Pacemaker malfunction
Evaluation and management of Pacemaker malfunctionPRAVEEN GUPTA
 
Air pollution and cardiovascular disease
Air pollution and cardiovascular diseaseAir pollution and cardiovascular disease
Air pollution and cardiovascular diseasePRAVEEN GUPTA
 
Chronic thromboembolic pulmonary hypertension (CTEPH)
Chronic thromboembolic pulmonary hypertension (CTEPH)Chronic thromboembolic pulmonary hypertension (CTEPH)
Chronic thromboembolic pulmonary hypertension (CTEPH)PRAVEEN GUPTA
 
ICD in Non-ischemic cardiomyopathy
ICD in Non-ischemic cardiomyopathyICD in Non-ischemic cardiomyopathy
ICD in Non-ischemic cardiomyopathyPRAVEEN GUPTA
 
2015 Jones criteria for the diagnosis of rheumatic fever
2015 Jones criteria for the diagnosis of rheumatic fever2015 Jones criteria for the diagnosis of rheumatic fever
2015 Jones criteria for the diagnosis of rheumatic feverPRAVEEN GUPTA
 
Non-Invasive physiological assessment of coronary circulatory function
Non-Invasive physiological assessment of coronary circulatory functionNon-Invasive physiological assessment of coronary circulatory function
Non-Invasive physiological assessment of coronary circulatory functionPRAVEEN GUPTA
 
Pulseless electrical activity, Ventricular flutter, Ventricular fibrillation
Pulseless electrical activity, Ventricular flutter, Ventricular fibrillationPulseless electrical activity, Ventricular flutter, Ventricular fibrillation
Pulseless electrical activity, Ventricular flutter, Ventricular fibrillationPRAVEEN GUPTA
 
Hybrid atrial fibrillation ablation
Hybrid atrial fibrillation ablationHybrid atrial fibrillation ablation
Hybrid atrial fibrillation ablationPRAVEEN GUPTA
 
Cardiology Journal club
Cardiology Journal clubCardiology Journal club
Cardiology Journal clubPRAVEEN GUPTA
 
Cardiovascular complication of cancer chemotherapy
Cardiovascular complication of cancer chemotherapyCardiovascular complication of cancer chemotherapy
Cardiovascular complication of cancer chemotherapyPRAVEEN GUPTA
 
Cardiology Journal scan
Cardiology Journal scanCardiology Journal scan
Cardiology Journal scanPRAVEEN GUPTA
 
SELECT-LV study (2017)
SELECT-LV study (2017)SELECT-LV study (2017)
SELECT-LV study (2017)PRAVEEN GUPTA
 
Wearable defibrillator
Wearable defibrillatorWearable defibrillator
Wearable defibrillatorPRAVEEN GUPTA
 
Diabetic cardiomyopathy (Pathophysiology)
Diabetic cardiomyopathy (Pathophysiology)Diabetic cardiomyopathy (Pathophysiology)
Diabetic cardiomyopathy (Pathophysiology)PRAVEEN GUPTA
 

More from PRAVEEN GUPTA (20)

Praveen's Indian cardiology board review and self-assessment
Praveen's Indian cardiology board review and self-assessmentPraveen's Indian cardiology board review and self-assessment
Praveen's Indian cardiology board review and self-assessment
 
Evaluation and management of Pacemaker malfunction
Evaluation and management of Pacemaker malfunctionEvaluation and management of Pacemaker malfunction
Evaluation and management of Pacemaker malfunction
 
Air pollution and cardiovascular disease
Air pollution and cardiovascular diseaseAir pollution and cardiovascular disease
Air pollution and cardiovascular disease
 
Chronic thromboembolic pulmonary hypertension (CTEPH)
Chronic thromboembolic pulmonary hypertension (CTEPH)Chronic thromboembolic pulmonary hypertension (CTEPH)
Chronic thromboembolic pulmonary hypertension (CTEPH)
 
ICD in Non-ischemic cardiomyopathy
ICD in Non-ischemic cardiomyopathyICD in Non-ischemic cardiomyopathy
ICD in Non-ischemic cardiomyopathy
 
2015 Jones criteria for the diagnosis of rheumatic fever
2015 Jones criteria for the diagnosis of rheumatic fever2015 Jones criteria for the diagnosis of rheumatic fever
2015 Jones criteria for the diagnosis of rheumatic fever
 
Non-Invasive physiological assessment of coronary circulatory function
Non-Invasive physiological assessment of coronary circulatory functionNon-Invasive physiological assessment of coronary circulatory function
Non-Invasive physiological assessment of coronary circulatory function
 
Cardiology mcq
Cardiology mcq Cardiology mcq
Cardiology mcq
 
Heart block
Heart blockHeart block
Heart block
 
Pulseless electrical activity, Ventricular flutter, Ventricular fibrillation
Pulseless electrical activity, Ventricular flutter, Ventricular fibrillationPulseless electrical activity, Ventricular flutter, Ventricular fibrillation
Pulseless electrical activity, Ventricular flutter, Ventricular fibrillation
 
Kawasaki diseases
Kawasaki diseasesKawasaki diseases
Kawasaki diseases
 
Hybrid atrial fibrillation ablation
Hybrid atrial fibrillation ablationHybrid atrial fibrillation ablation
Hybrid atrial fibrillation ablation
 
Cardiology Journal club
Cardiology Journal clubCardiology Journal club
Cardiology Journal club
 
AICD programming
AICD programmingAICD programming
AICD programming
 
Cardiovascular complication of cancer chemotherapy
Cardiovascular complication of cancer chemotherapyCardiovascular complication of cancer chemotherapy
Cardiovascular complication of cancer chemotherapy
 
Cardiology Journal scan
Cardiology Journal scanCardiology Journal scan
Cardiology Journal scan
 
SELECT-LV study (2017)
SELECT-LV study (2017)SELECT-LV study (2017)
SELECT-LV study (2017)
 
Wearable defibrillator
Wearable defibrillatorWearable defibrillator
Wearable defibrillator
 
Diabetic cardiomyopathy (Pathophysiology)
Diabetic cardiomyopathy (Pathophysiology)Diabetic cardiomyopathy (Pathophysiology)
Diabetic cardiomyopathy (Pathophysiology)
 
Heart sounds
Heart soundsHeart sounds
Heart sounds
 

Recently uploaded

The Most Excellent Way | 1 Corinthians 13
The Most Excellent Way | 1 Corinthians 13The Most Excellent Way | 1 Corinthians 13
The Most Excellent Way | 1 Corinthians 13Steve Thomason
 
Contemporary philippine arts from the regions_PPT_Module_12 [Autosaved] (1).pptx
Contemporary philippine arts from the regions_PPT_Module_12 [Autosaved] (1).pptxContemporary philippine arts from the regions_PPT_Module_12 [Autosaved] (1).pptx
Contemporary philippine arts from the regions_PPT_Module_12 [Autosaved] (1).pptxRoyAbrique
 
microwave assisted reaction. General introduction
microwave assisted reaction. General introductionmicrowave assisted reaction. General introduction
microwave assisted reaction. General introductionMaksud Ahmed
 
POINT- BIOCHEMISTRY SEM 2 ENZYMES UNIT 5.pptx
POINT- BIOCHEMISTRY SEM 2 ENZYMES UNIT 5.pptxPOINT- BIOCHEMISTRY SEM 2 ENZYMES UNIT 5.pptx
POINT- BIOCHEMISTRY SEM 2 ENZYMES UNIT 5.pptxSayali Powar
 
Separation of Lanthanides/ Lanthanides and Actinides
Separation of Lanthanides/ Lanthanides and ActinidesSeparation of Lanthanides/ Lanthanides and Actinides
Separation of Lanthanides/ Lanthanides and ActinidesFatimaKhan178732
 
call girls in Kamla Market (DELHI) 🔝 >༒9953330565🔝 genuine Escort Service 🔝✔️✔️
call girls in Kamla Market (DELHI) 🔝 >༒9953330565🔝 genuine Escort Service 🔝✔️✔️call girls in Kamla Market (DELHI) 🔝 >༒9953330565🔝 genuine Escort Service 🔝✔️✔️
call girls in Kamla Market (DELHI) 🔝 >༒9953330565🔝 genuine Escort Service 🔝✔️✔️9953056974 Low Rate Call Girls In Saket, Delhi NCR
 
MENTAL STATUS EXAMINATION format.docx
MENTAL     STATUS EXAMINATION format.docxMENTAL     STATUS EXAMINATION format.docx
MENTAL STATUS EXAMINATION format.docxPoojaSen20
 
Employee wellbeing at the workplace.pptx
Employee wellbeing at the workplace.pptxEmployee wellbeing at the workplace.pptx
Employee wellbeing at the workplace.pptxNirmalaLoungPoorunde1
 
Science 7 - LAND and SEA BREEZE and its Characteristics
Science 7 - LAND and SEA BREEZE and its CharacteristicsScience 7 - LAND and SEA BREEZE and its Characteristics
Science 7 - LAND and SEA BREEZE and its CharacteristicsKarinaGenton
 
CARE OF CHILD IN INCUBATOR..........pptx
CARE OF CHILD IN INCUBATOR..........pptxCARE OF CHILD IN INCUBATOR..........pptx
CARE OF CHILD IN INCUBATOR..........pptxGaneshChakor2
 
Enzyme, Pharmaceutical Aids, Miscellaneous Last Part of Chapter no 5th.pdf
Enzyme, Pharmaceutical Aids, Miscellaneous Last Part of Chapter no 5th.pdfEnzyme, Pharmaceutical Aids, Miscellaneous Last Part of Chapter no 5th.pdf
Enzyme, Pharmaceutical Aids, Miscellaneous Last Part of Chapter no 5th.pdfSumit Tiwari
 
Interactive Powerpoint_How to Master effective communication
Interactive Powerpoint_How to Master effective communicationInteractive Powerpoint_How to Master effective communication
Interactive Powerpoint_How to Master effective communicationnomboosow
 
Introduction to AI in Higher Education_draft.pptx
Introduction to AI in Higher Education_draft.pptxIntroduction to AI in Higher Education_draft.pptx
Introduction to AI in Higher Education_draft.pptxpboyjonauth
 
Accessible design: Minimum effort, maximum impact
Accessible design: Minimum effort, maximum impactAccessible design: Minimum effort, maximum impact
Accessible design: Minimum effort, maximum impactdawncurless
 
Incoming and Outgoing Shipments in 1 STEP Using Odoo 17
Incoming and Outgoing Shipments in 1 STEP Using Odoo 17Incoming and Outgoing Shipments in 1 STEP Using Odoo 17
Incoming and Outgoing Shipments in 1 STEP Using Odoo 17Celine George
 
Hybridoma Technology ( Production , Purification , and Application )
Hybridoma Technology  ( Production , Purification , and Application  ) Hybridoma Technology  ( Production , Purification , and Application  )
Hybridoma Technology ( Production , Purification , and Application ) Sakshi Ghasle
 
KSHARA STURA .pptx---KSHARA KARMA THERAPY (CAUSTIC THERAPY)————IMP.OF KSHARA ...
KSHARA STURA .pptx---KSHARA KARMA THERAPY (CAUSTIC THERAPY)————IMP.OF KSHARA ...KSHARA STURA .pptx---KSHARA KARMA THERAPY (CAUSTIC THERAPY)————IMP.OF KSHARA ...
KSHARA STURA .pptx---KSHARA KARMA THERAPY (CAUSTIC THERAPY)————IMP.OF KSHARA ...M56BOOKSTORE PRODUCT/SERVICE
 

Recently uploaded (20)

The Most Excellent Way | 1 Corinthians 13
The Most Excellent Way | 1 Corinthians 13The Most Excellent Way | 1 Corinthians 13
The Most Excellent Way | 1 Corinthians 13
 
Contemporary philippine arts from the regions_PPT_Module_12 [Autosaved] (1).pptx
Contemporary philippine arts from the regions_PPT_Module_12 [Autosaved] (1).pptxContemporary philippine arts from the regions_PPT_Module_12 [Autosaved] (1).pptx
Contemporary philippine arts from the regions_PPT_Module_12 [Autosaved] (1).pptx
 
microwave assisted reaction. General introduction
microwave assisted reaction. General introductionmicrowave assisted reaction. General introduction
microwave assisted reaction. General introduction
 
POINT- BIOCHEMISTRY SEM 2 ENZYMES UNIT 5.pptx
POINT- BIOCHEMISTRY SEM 2 ENZYMES UNIT 5.pptxPOINT- BIOCHEMISTRY SEM 2 ENZYMES UNIT 5.pptx
POINT- BIOCHEMISTRY SEM 2 ENZYMES UNIT 5.pptx
 
Separation of Lanthanides/ Lanthanides and Actinides
Separation of Lanthanides/ Lanthanides and ActinidesSeparation of Lanthanides/ Lanthanides and Actinides
Separation of Lanthanides/ Lanthanides and Actinides
 
call girls in Kamla Market (DELHI) 🔝 >༒9953330565🔝 genuine Escort Service 🔝✔️✔️
call girls in Kamla Market (DELHI) 🔝 >༒9953330565🔝 genuine Escort Service 🔝✔️✔️call girls in Kamla Market (DELHI) 🔝 >༒9953330565🔝 genuine Escort Service 🔝✔️✔️
call girls in Kamla Market (DELHI) 🔝 >༒9953330565🔝 genuine Escort Service 🔝✔️✔️
 
MENTAL STATUS EXAMINATION format.docx
MENTAL     STATUS EXAMINATION format.docxMENTAL     STATUS EXAMINATION format.docx
MENTAL STATUS EXAMINATION format.docx
 
Employee wellbeing at the workplace.pptx
Employee wellbeing at the workplace.pptxEmployee wellbeing at the workplace.pptx
Employee wellbeing at the workplace.pptx
 
Model Call Girl in Tilak Nagar Delhi reach out to us at 🔝9953056974🔝
Model Call Girl in Tilak Nagar Delhi reach out to us at 🔝9953056974🔝Model Call Girl in Tilak Nagar Delhi reach out to us at 🔝9953056974🔝
Model Call Girl in Tilak Nagar Delhi reach out to us at 🔝9953056974🔝
 
Science 7 - LAND and SEA BREEZE and its Characteristics
Science 7 - LAND and SEA BREEZE and its CharacteristicsScience 7 - LAND and SEA BREEZE and its Characteristics
Science 7 - LAND and SEA BREEZE and its Characteristics
 
TataKelola dan KamSiber Kecerdasan Buatan v022.pdf
TataKelola dan KamSiber Kecerdasan Buatan v022.pdfTataKelola dan KamSiber Kecerdasan Buatan v022.pdf
TataKelola dan KamSiber Kecerdasan Buatan v022.pdf
 
CARE OF CHILD IN INCUBATOR..........pptx
CARE OF CHILD IN INCUBATOR..........pptxCARE OF CHILD IN INCUBATOR..........pptx
CARE OF CHILD IN INCUBATOR..........pptx
 
Enzyme, Pharmaceutical Aids, Miscellaneous Last Part of Chapter no 5th.pdf
Enzyme, Pharmaceutical Aids, Miscellaneous Last Part of Chapter no 5th.pdfEnzyme, Pharmaceutical Aids, Miscellaneous Last Part of Chapter no 5th.pdf
Enzyme, Pharmaceutical Aids, Miscellaneous Last Part of Chapter no 5th.pdf
 
Interactive Powerpoint_How to Master effective communication
Interactive Powerpoint_How to Master effective communicationInteractive Powerpoint_How to Master effective communication
Interactive Powerpoint_How to Master effective communication
 
Staff of Color (SOC) Retention Efforts DDSD
Staff of Color (SOC) Retention Efforts DDSDStaff of Color (SOC) Retention Efforts DDSD
Staff of Color (SOC) Retention Efforts DDSD
 
Introduction to AI in Higher Education_draft.pptx
Introduction to AI in Higher Education_draft.pptxIntroduction to AI in Higher Education_draft.pptx
Introduction to AI in Higher Education_draft.pptx
 
Accessible design: Minimum effort, maximum impact
Accessible design: Minimum effort, maximum impactAccessible design: Minimum effort, maximum impact
Accessible design: Minimum effort, maximum impact
 
Incoming and Outgoing Shipments in 1 STEP Using Odoo 17
Incoming and Outgoing Shipments in 1 STEP Using Odoo 17Incoming and Outgoing Shipments in 1 STEP Using Odoo 17
Incoming and Outgoing Shipments in 1 STEP Using Odoo 17
 
Hybridoma Technology ( Production , Purification , and Application )
Hybridoma Technology  ( Production , Purification , and Application  ) Hybridoma Technology  ( Production , Purification , and Application  )
Hybridoma Technology ( Production , Purification , and Application )
 
KSHARA STURA .pptx---KSHARA KARMA THERAPY (CAUSTIC THERAPY)————IMP.OF KSHARA ...
KSHARA STURA .pptx---KSHARA KARMA THERAPY (CAUSTIC THERAPY)————IMP.OF KSHARA ...KSHARA STURA .pptx---KSHARA KARMA THERAPY (CAUSTIC THERAPY)————IMP.OF KSHARA ...
KSHARA STURA .pptx---KSHARA KARMA THERAPY (CAUSTIC THERAPY)————IMP.OF KSHARA ...
 

Cardiac catheteriztion, Oximetery study in a patient with VSD

  • 2. History  A 40 year old female resident of Bankura, West Bengal came to JIPMER hospital cardiology OPD with chief complaints of  Dypnoea on exertion NYHA Class III since 2 month  Chest pain since last one month 2
  • 3. On examination  Cyanosis+/Clubbing +/Icterus-/LAP-  Pulse- 71 beats per min  BP-110/70 mmhg  CVS-S1S2 + S2 Loud  RS-Bilateral NVBS+  SPO2-90% 3
  • 4. Investigation  Hb-15.5  Platelet count 1.5 lacs  RBS-74  BUN-33  S.Creatinine-1.4  Uric acid-2.5  HIV-NR  HBsAg-NR  Anti HCV- Negative  Body weight-37 kgs  Height-144 cms 4
  • 5. Investigation  ECG-Normal sinus rhythm at 60 beats per minute, right axis deivation, right ventricular hypertrophy  Echocardiography Large muscular VSD with bidirectional shunt was present, Severe tricuspid regurgitaion with RVSP 130 mmhg, IAS was intact, no PDA, CoA, Normal biventricular function 5
  • 6. Course in the hospital  VSD with Severe pulmonary hypertension  Planned for cardiac catheterization to look for feasbility for surgical repair.  But cardiac catheterization was not possible in view of logistic reason so patient was discharged and advised to follow up in cardiology OPD.  Patient was started on tablet Sildenafil 25 mg TDS  Patient again visited JIPMER after six month  During this admission her Spo2 was 95%, and she was found to be HCV positive  So cath study was planned 6
  • 7. Cath study (Oximetery run ) Pre-oxygenation Post oxygentaion (100% O2) SVC 58.8% 70.8% IVC 74.9% 75.9% Right atrium 62% 84% Right ventricle 77.3% 91.1% Pulmonary artery 87.4% 91.2% Pulmonary vein 92.7% 98.3% Left atrium 88.1% 96% Left ventricle 96% 99.3% Aorta 92.1% 94.5% Mixed venous oxygen satuation 62.82% 72.07 7
  • 10. Pressure in various cardiac chamber during cath study(Post-oxygenation) Systolic pressure (mmhg) Diastolic pressure (mmhg) Mean Pressure(mmhg) Right atrium 6 Left atrium 6 Pulmonary artery 88 40 62 Aorta 98 67 77 10
  • 11. Oxygen content calculation Chamber Oxygen content calculation Oxygen content SVC 0.136X10X70.8+0.03X63 98.17 IVC 0.136 X 10 X 75.9 + 0.03 X 52 104.784 Pul Artery 0.136 x 10 x91.2 + 0.03 x 132 127.992 Pul venous 0.136 X 10 X 98.3 + 0.03 X 450 147.188 Aorta 0.136 x 10 x 94.5 + 0.03 x 40.4 140.64 Mixed venous oxyg saturation 3 x SCV + 1 X IVC/ 4 99.82 11
  • 12. Cath study data BSA 1.22 m2 Vmax 150 x BSA 184.37 Qs(Systemic blood flow) Vmax/Ao2-MVo2 4.51 Qp(Pulmonary blood flow) Vmax/Pvo2-Pao2 9.60 Qp/QS 9.60/4.51 2.12 EBF(Effective blood flow) Vmax/Pvo2-MVo2 4.091 12
  • 13. Cath study data PVR Pa(mean)-LA(mean)/Qp 62-6/9.60 5.88 wood unit SVR Ao(mean)-RA(mean)/Qs 77-6/4.51 15.63 wood unit PVR/SVR 5.88/12.41 0.3761 L-R Shunt PBF-EBF 9.60-4.091 5.509 R-L Shunt SBF-EBF 4.51-4.091 0.419 13
  • 14. Conclusion  VSD/Severe PAH/Bidirectional shunt/moderate pulmonary vascular resistance  Plan-Medical management with intracardiac repair for VSD 14
  • 15. Shunt Determinations  Normally, PBF and SBF are equal  With abnormal communication between intracardiac chambers or great vessels, blood flow is shunted from the systemic circulation to the pulmonary circulation (left-to-right shunt), from the pulmonary circulation to the systemic circulation (right-to-left shunt), or in both directions (bidirectional shunt).  Most commonly method for shunt determination, oximetric method  Unexplained pulmonary artery oxygen saturation > 80% raise suspicion for left-to-right shunt  Unexplained arterial desaturation (<93%) indicate a right-to-left shunt  If arterial desaturation persists after the patient takes several deep breaths or after administration of 100% oxygen, a right-to-left shunt is likely 15
  • 16. Oximetric Method  The oximetric method is based on blood sampling from various cardiac chambers for determination of oxygen saturation  Left-to-right shunt is detected when a significant increase in blood oxygen saturation is found between two right-sided vessels or chambers  Obtains blood samples from all right-sided locations  A full saturation run obtains samples from the high and low IVC; high and low SVC; high, middle, and low right atrium; RV inflow and outflow tracts and midcavity; main pulmonary artery; left or right pulmonary artery; pulmonary vein and left atrium, if possible; left ventricle; and distal aorta 16
  • 17. Shunt Quantification  To determine left to- right shunt, PBF and SBF required  Principles of Fick cardiac output are used to quantify intracardiac shunts  PBF is oxygen consumption/ difference in oxygen content across pulmonary bed  SBF is oxygen consumption/difference in oxygen content across the systemic bed  Effective blood flow (EBF) is the fraction of mixed venous return received by the lungs without contamination by shunt flow  In the absence of a shunt, PBF, SBF, and EBF are all equal 17
  • 18. Shunt Quantification where PvO2, PaO2, SaO2, and MvO2 are the oxygen content (in milliliters of oxygen per liter of blood) of pulmonary venous, pulmonary arterial, systemic arterial, and mixed venous blood, respectively 18
  • 19. Shunt Quantification  The mixed venous oxygen content is the average oxygen content of blood in the chamber proximal to the shunt.  When assessing a left-to-right shunt at the level of the right atrium, one must calculate the mixed venous oxygen content on the basis of the contributing blood flow from the IVC, SVC, and coronary sinus.  The most commonly used method is the Flamm formula 19
  • 20. Shunt Quantification  Assuming conservation of mass, the size of a left-to-right shunt, when no associated right-to- left shunt is present, is simply LR shunt = PBF − SBF  When there is evidence of a right-to-left shunt in addition to a left to- right shunt (also referred to as a bidirectional shunt), the approximate size of the left-to-right shunt is LR shunt = PBF − EBF  Approximate size of the right-to-left shunt is RL shunt = SBF − EBF 20
  • 21. Shunt Quantification  Flow ratio PBF/SBF (or Qp/Qs) is used clinically to determine the significance of the shunt  Ratio of less than 1.5 indicates a small left-to-right shunt  Ratio of 1.5 to 2.0, a moderate-sized shunt  Ratio of 2.0 or higher indicates a large left-to-right shunt  A flow ratio of less than 1.0 indicates a net right-to-left shunt 21
  • 22. Various formula used are---  A-VO2 is the arterial-venous oxygen saturation difference  Hgb is the hemoglobin concentration (mg/dL), and the constant 1.36 is the oxygen-carrying capacity of hemoglobin (expressed in mL O2/g Hgb)  Systemic vascular resistance (SVR) in absolute units is calculated with the following equation:  Aom and RAm are the mean pressure (in mm Hg) in the aorta and right atrium, respectively, and Qs is systemic cardiac output (in liters/min).  The constant 80 is used to convert units from mm Hg/liter/ min (Wood units) to the absolute resistance units dyne-sec • cm−5 22
  • 23. Various formula used are---  where PAm and LAm are mean pulmonary artery and left atrial pressure, respectively, and Qp is PBF.  If mean left atrial pressure has not been measured directly, mean pulmonary capillary wedge pressure is commonly substituted for it, although errors can occur because of this substitution.  In the absence of an intracardiac shunt, Qp is equal to systemic cardiac output.  PVR describes the pressure across the major pulmonary vessels and the precapillary arterioles and pulmonary 23
  • 24. 24
  • 25. Operative criteria in a patient with intracardia shunt 25
  • 26. Operative criteria 26  The use of a PVR of 6 Wood units m2 and a PVR∶SVR ratio of 0.3 as limits for considering operation in PAH-CHD was proposed in a previously published consensus  20% decrease in PVR from baseline during the acute vasodilator test was considered sufficient to define a positive response but not to characterize operability  More recently, during the 5th World Symposium on Pulmonary Hypertension of the World Health Organization (Nice, France, February 2013), a PVR of 4 Wood units m2 was proposed as a limit for considering surgery, and a PVR of 4–8 Wood units m2 as the range in which patients should be discussed case by case.
  • 27. Operative criteria 27  The Pediatric Task Force also concluded that at present, there is no established protocol for the vasodilator test in children and no evidence to use it for prognostic purposes.  There has been debate about what to do with patients with elevated PVR (e.g., PVR > 8–10 Wood units m2and PVR∶SVR > 0.5), in particular since the answer will not be the same for patients at different ages
  • 28. 28